Paper30188112
Quercetin Inlaid Silk Fibroin/Hydroxyapatite Scaffold Promotes Enhanced Osteogenesis.
Song JE and 4 others. ACS Appl Mater Interfaces, 2018. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Quercetin Inlaid Silk Fibroin/Hydroxyapatite Scaffold Promotes Enhanced Osteogenesis. Papers, record 30188112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30188112
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Durapatite | Major topic |
| Fibroins | Major topic |
| Quercetin | Major topic |
| Tissue Scaffolds | Major topic |
| Animals | |
| Biocompatible Materials | |
| Cell Differentiation | |
| Cell Proliferation | |
| Cells, Cultured | |
| Female | |
| Microscopy, Electron, Scanning | |
| Osteogenesis | |
| Porosity | |
| Rabbits | |
| Rats, Sprague-Dawley | |
| Real-Time Polymerase Chain Reaction | |
| Spectroscopy, Fourier Transform Infrared |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42865699 | A smart MMP-9-responsive hydrogel releasing quercetin for psoriasis therapy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42865699 | PubMed |
| 42422063 | Quercetin in bone regeneration: optimization of drug delivery system and study of its synergistic mechanism with bone tissue engineering. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42422063 | PubMed |
| 41965753 | Quercetin-loaded composite materials for bone regeneration: a review of carriers, controlled release, and mechanistic advances. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41965753 | PubMed |
| 41226117 | Polyphenols and Bone Health: A Comprehensive Review of Their Role in Osteoporosis Prevention and Treatment. | Molecules | 2025 | https://conductscience.org/library/papers/41226117 | PubMed |
| 40977869 | Natural Polyphenols and Mesenchymal Stem Cells: A New Insight in Bone Regenerative Medicine. | Stem Cells Int | 2025 | https://conductscience.org/library/papers/40977869 | PubMed |
| 40918947 | Phytochemicals in Bone Therapy: Exploring Natural Alternatives for Bone Health. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40918947 | PubMed |
| 40635717 | Materials, Syntheses and Biomedical Applications of Nano-Quercetin Formulations: A Comprehensive Literature Review. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40635717 | PubMed |
| 39061858 | Application of Antioxidant Compounds in Bone Defect Repair. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061858 | PubMed |
| 38226016 | A multifunctional quercetin/polycaprolactone electrospun fibrous membrane for periodontal bone regeneration. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/38226016 | PubMed |
| 38089090 | Resorbable Membranes for Guided Bone Regeneration: Critical Features, Potentials, and Limitations. | ACS Mater Au | 2023 | https://conductscience.org/library/papers/38089090 | PubMed |
| 37877225 | Bioactive Scaffolds as a Promising Alternative for Enhancing Critical-Size Bone Defect Regeneration in the Craniomaxillofacial Region. | ACS Appl Bio Mater | 2023 | https://conductscience.org/library/papers/37877225 | PubMed |
| 37836731 | Flavonoid-Loaded Biomaterials in Bone Defect Repair. | Molecules | 2023 | https://conductscience.org/library/papers/37836731 | PubMed |
| 37077623 | Quercetin-solid lipid nanoparticle-embedded hyaluronic acid functionalized hydrogel for immunomodulation to promote bone reconstruction. | Regen Biomater | 2023 | https://conductscience.org/library/papers/37077623 | PubMed |
| 36984115 | Polymeric and Composite Carriers of Protein and Non-Protein Biomolecules for Application in Bone Tissue Engineering. | Materials (Basel) | 2023 | https://conductscience.org/library/papers/36984115 | PubMed |
| 36686706 | Research progress of natural silk fibroin and the application for drug delivery in chemotherapies. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36686706 | PubMed |
| 35462886 | The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35462886 | PubMed |
| 35387171 | Surface modification of titanium substrate via combining photothermal therapy and quorum-sensing-inhibition strategy for improving osseointegration and treating biofilm-associated bacterial infection. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35387171 | PubMed |
| 35252158 | Traditional Chinese Medicine Compound-Loaded Materials in Bone Regeneration. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35252158 | PubMed |
| 35128373 | Sustained release of naringin from silk-fibroin-nanohydroxyapatite scaffold for the enhancement of bone regeneration. | Mater Today Bio | 2022 | https://conductscience.org/library/papers/35128373 | PubMed |
| 34776987 | Bioactive Herbal Extracts of Traditional Chinese Medicine Applied with the Biomaterials: For the Current Applications and Advances in the Musculoskeletal System. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34776987 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30188112
GET https://conductscience.org/api/papers/v1/30188112/cited_by?page=2